Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6). - sprookjes - yvandenbroek - TriplyDB

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).

http://www.wikidata.org/entity/Q37625427

about

Genomic analysis to guide choice of treatment for smoking cessation A review of pharmacogenetic studies of substance-related disorders Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions.Nicotine withdrawal.Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors.The Genetics, Neurogenetics and Pharmacogenetics of Addiction Re-defininG AddiC(CH3)Tion: genomics and epigenomics on substance use disorders.Pathways to precision medicine in smoking cessation treatments.Pharmacogenetic Optimization of Smoking Cessation Treatment.Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date.A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.Smokescreen: a targeted genotyping array for addiction research Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers.Gender Considerations in Addiction: Implications for Treatment.Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers Leveraging genomic data in smoking cessation trials in the era of Precision Medicine: Why and how.Nicotine Metabolism in Young Adult Daily Menthol and Nonmenthol Smokers Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.Genetics and smoking.Use of hormonal contraceptives and smoking cessation: A preliminary report.To quit or not: Vulnerability of women to smoking tobacco.Effectiveness of Switching Smoking-Cessation Medications Following Relapse.The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings.Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women.A Novel Tobacco Use Phenotype Suggests the 15q25 and 19q13 Loci May be Differentially Associated With Cigarettes per Day and Tobacco-Related Problems.Significant association of the CHRNB3-CHRNA6 gene cluster with nicotine dependence in the Chinese Han population.CYP2A6 metabolism in the development of smoking behaviors in young adults.Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings From ITC Surveys in Five Countries.Variation in CYP2A6 Activity and Personalized Medicine.Preparing the Way: Exploiting Genomic Medicine to Stop Smoking.Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism.Lessons Learned From Past Gene-Environment Interaction Successes.Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.Does menthol cigarette use moderate the effect of nicotine metabolism on short-term smoking cessation?Biosignature Discovery for Substance Use Disorders Using Statistical Learning.Commentary on Chen et al. (2014): another step on the road to clinical utility of pharmacogenetics for smoking cessation?Smoking cessation in pregnancy: a continuing challenge in the United States

P2860

Q24188234-32580508-D58D-4EEF-849F-3B47059E865E Q27312296-8DBF4FCF-CD10-4CEF-A29B-B8994D75D219 Q28397614-2FC699E2-0B5A-40C1-813E-2F3DFDB89D31 Q30276828-CFB705AE-3342-4743-AF31-7C1E7527A60D Q30404700-04CDA56C-2B7F-44C8-A757-4BFD0287AB73 Q33458739-82F78F50-66A8-46EA-A2EC-291B886AE21B Q33898930-28E0EBE2-178B-43B3-8FC7-AA1CC44238C0 Q33960773-480F7D08-4669-4F3F-90C2-E6AAD4169992 Q34527740-ACC49AD8-1496-42B4-B74B-6C145D1811CB Q34542169-6A860536-E879-46E6-A458-B4B2A9E308AD Q35641707-55133F28-C3B4-486B-8134-11773340D682 Q35751986-C5BD0797-84AA-4A17-AC7B-833C78B0BA93 Q35788753-82A9ED06-E833-4F79-B2CC-45392002B13C Q35938102-543D837B-7A61-45D8-B99B-008C7F8DE322 Q35956179-634CE04A-7606-4EC0-B64C-17E83DB42254 Q35974715-3A9F0E56-6340-4A52-9A49-AFA4970EBFCD Q36082618-C5EA3DC1-3BF2-4EFB-AB74-4362C9F967B1 Q36303865-8675E650-DE53-4769-B183-6EFEA3BD6222 Q36370325-B9B3BCE9-201C-4B5C-A969-B3E177D75198 Q36870991-F59DE492-1594-42FE-8565-2A15A4FE7D2B Q37163230-0045DF01-5775-4B26-A74C-AB58C2B344CE Q37723880-D8049F49-9DFE-4DE9-9CBE-5BE64497ADA3 Q38597751-3159D699-6573-41D8-8B44-372D29A8B15C Q38669817-4B53B5A5-9F91-4AC5-876F-F8E152FBAA95 Q38740690-F9E66C2E-D78A-4B4D-99D0-2E703DBB2329 Q39284073-5D996C4F-F258-41AE-AC9F-3FD9063ACB4C Q39337794-DEED8976-6258-483F-B533-E87FAD874489 Q39355985-2917F598-8604-4B2B-BCEB-E930CE8E77B8 Q40075634-4628BEAC-B1C3-4A77-A45E-63DB63160E75 Q40403514-53AA8B0C-7CB8-4520-B852-497FCB1D5906 Q46586422-175C3E42-B0D0-4235-B285-5DC976216755 Q47163198-FA508AC7-AA3D-4920-BD2F-2D30A8642B03 Q47200916-CF68B513-69D3-4482-B848-9FFC391E0708 Q47565250-FCD4A0A2-2C99-40F1-9DEF-786321400377 Q47915070-A79C7233-566F-4646-BC76-71288456E8C0 Q48015634-7AC3571A-641B-4044-9640-F33F957E874E Q48158115-DDDCC4C1-40B1-41B8-8FE4-A60331235182 Q50154619-DA92705C-A8DD-455D-98CD-CCE863F9089A Q52303929-3E4856A1-2F67-45A2-B201-B903FEDC1399 Q58574184-E46C2778-AB30-45C7-A58F-4693D1326D09

P2860

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).

http://www.wikidata.org/entity/Q37625427

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).

@en

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene

@nl

type

label

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).

@en

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene

@nl

prefLabel

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).

@en

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene

@nl

P1433

Q37625427-EFAFF7B9-B772-4170-9CCB-05AAFE939EEA

P1476

Q37625427-A1841B78-03D5-45C5-842F-0F1CECF54F0B

P2093

Q37625427-0667C049-FFF0-4B96-A4FF-1A46A828FDFA

Q37625427-620BD3A9-DE32-4B94-BA0E-9603B25B4689

Q37625427-A7F61A16-3420-4DD0-B476-A7A02EF2FFF1

Q37625427-BD317DB8-B9A3-478B-BAC5-4AA3572BA213

Q37625427-C510DDC0-DDDC-4BF0-BCF5-C5E2AAF22309

Q37625427-CDC3351C-D682-438C-8FB2-81E5CAD45918

P2860

Q37625427-026657AE-97F3-402B-B8A6-81B0DD0A31D5

Q37625427-08FA4F20-D409-4510-853F-F84205EE1E08

Q37625427-11C476E8-DE3E-4273-A3E8-0C129EF35926

Q37625427-1CDA5DE3-325F-4A4E-AA26-1A029C293B9A

Q37625427-34B70463-43D8-49E4-A9D2-D84C4B9D991F

Q37625427-3A990D66-1892-4D22-B3F7-40F6E19242B7

Q37625427-4292F6D3-292F-47DE-A1CF-F71E27DF78FD

Q37625427-4777598B-4A3B-495A-8128-63A3A22C777D

Q37625427-49EECFED-34B3-4D9B-AC65-9889A2CA3C61

Q37625427-4EAD8B27-408C-4BB7-B8E6-6A8865FD05C5

P304

Q37625427-5497A906-E532-4BCB-9973-7744CBF3A157

P31

Q37625427-AC0BF6E6-7467-4339-87B9-879588A7D9F4

P356

Q37625427-39BB5590-5641-4194-BCC4-C522E74144DE

P407

Q37625427-4C790679-F820-41DC-BF56-2F75BEEFEE8D

P433

Q37625427-36F0CEAB-96EC-4531-BA0D-66437300D206

P478

Q37625427-300186B2-5A48-4FD6-9C1F-6318F9AD7FEB

P50

Q37625427-12AF0A51-F189-4E7C-A5C4-698AF7F53936

Q37625427-40A9F3E3-19C7-4E46-8D68-605CFE4F33B5

Q37625427-792D58DD-AACA-49AE-A17A-A88C7F4E5A65

Q37625427-94830C2C-EEC2-4BA3-9138-69DD2667FA32

P577

Q37625427-69525A84-7B68-4ACE-A6E2-6A5FD624D0DA

P5875

Q37625427-57A6EECE-D987-4AC6-AC4A-8318341D55A3

P698

Q37625427-99DFA9AC-BDD4-458F-ADA2-AA85901CD0D9

P921

Q37625427-7BF2377D-AA66-4429-9D9C-EA249148CA94

P932

Q37625427-BA2CC42B-060C-4708-A991-F6CAA8FE0744

P356

P1433

P1476

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).

@en

P2093

Li-Shiun Chen

http://www.w3.org/2001/XMLSchema#string

Maribel Martinez

http://www.w3.org/2001/XMLSchema#string

Megan E Piper

http://www.w3.org/2001/XMLSchema#string

Nancy Saccone

http://www.w3.org/2001/XMLSchema#string

Stevens S Smith

http://www.w3.org/2001/XMLSchema#string

Timothy B Baker

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis and imputation refines the association of 15q25 with smoking quantity

Genome-wide meta-analyses identify multiple loci associated with smoking behavior.

Molecular genetics of successful smoking cessation: convergent genome-wide association study results

PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6

Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.

Measurement of self reported active exposure to cigarette smoke

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

Individual patient data meta-analysis of diagnostic studies: opportunities and challenges.

A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior.

P304

128-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ADD.12353

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Laura J. Bierut

Dorothy Hatsukami

P577

2013-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256607999

http://www.w3.org/2001/XMLSchema#string

P698

24033696

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

3946972

http://www.w3.org/2001/XMLSchema#string